NCT01486862 Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs Status COMPLETED Phase PHASE4
NCT01486381 Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01484262 Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2 Status COMPLETED Phase N/A
NCT01480180 Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A Status COMPLETED Phase PHASE3
NCT01477632 Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women Status COMPLETED Phase PHASE1
NCT01476423 Observational Registry of the Treatment of Glanzmann's Thrombasthenia Status COMPLETED Phase N/A
NCT01473953 Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01472640 The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT01469143 A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01467427 Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. Status COMPLETED Phase PHASE3
NCT01467414 A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes Status TERMINATED Phase PHASE1
NCT01467401 Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01467375 Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01467323 Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01467141 Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes Status COMPLETED Phase PHASE4
NCT01465152 Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01464099 Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01463449 "Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?" Status COMPLETED Phase N/A
NCT01455142 A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01454024 Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice Status COMPLETED Phase N/A